ReviewNanomaterials (Basel, Switzerland)2022
A Review of Advancing Two-Dimensional Material Membranes for Ultrafast and Highly Selective Liquid Separation.
Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- A Dual-Role Amphiphilic Photosensitizer: Enhancing Structural Uniformity and Optical Properties of Langmuir Monolayers.Langmuir : the ACS journal of surfaces and colloids · 2026Article
- Multifunctional PVDF membranes incorporating graphene, TiORSC advances · 2025Article
- Editorial for the Special Issue "Preparation and Application of Advanced Functional Membranes".Membranes · 2024Article
- Review: chitosan-based biopolymers for anion-exchange membrane fuel cell application.Royal Society open science · 2023Review
- Polycation-Intercalated MXene Membrane with Enhanced Permselective and Anti-Microbial Properties.Nanomaterials (Basel, Switzerland) · 2023Article
- Nanodiamond embedded polyaniline/polyvinylidene fluoride nanocomposites as microfiltration membranes for removal of industrial pollution.RSC advances · 2023Article
- Research on the Antibacterial Properties of MXene-Based 2D-2D Composite Materials Membrane.Nanomaterials (Basel, Switzerland) · 2023Article
- Response of Bilayer and Trilayer Graphene to High-Energy Heavy Ion Irradiation.Materials (Basel, Switzerland) · 2023Article
- Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer's Disease.Journal of clinical medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Membrane-based nanotechnology possesses high separation efficiency, low economic and energy consumption, continuous operation modes and environmental benefits, and has been utilized in various separation fields. Two-dimensional nanomaterials (2DNMs) with unique atomic thickness have rapidly emerged as ideal building blocks to develop high-performance separation membranes. By rationally tailoring and precisely controlling the nanochannels and/or nanoporous apertures of 2DNMs, 2DNM-based membranes are capable of exhibiting unprecedentedly high permeation and selectivity properties. In this review, the latest breakthroughs in using 2DNM-based membranes as nanosheets and laminar membranes are summarized, including their fabrication, structure design, transport behavior, separation mechanisms, and applications in liquid separations. Examples of advanced 2D material (graphene family, 2D TMDs, MXenes, metal-organic frameworks, and covalent organic framework nanosheets) membrane designs with remarkably perm-selective properties are highlighted. Additionally, the development of strategies used to functionalize membranes with 2DNMs are discussed. Finally, current technical challenges and emerging research directions of advancing 2DNM membranes for liquid separation are shared.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.